ANKAM INC. financials

ANKM CIK 0001781629

Source: EDGAR filings · Built 2026-06-19T01:58:34Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2022
EBITDA -273.10K
Working Capital -443.10K -428.63K -347.46K -315.35K -29.93K
Net Debt -57 336.64K 212.74K 33.20K
Gross Margin 53.88% 100.00%
Operating Margin -20.67% -278.75% -1096.85%
Net Margin -20.66% -131.02% -1027.33% -3141.53%
Return on Equity (ROE) 17.16% 42.22% 85.81% 119.82% 91.64%
Return on Assets (ROA) -36.58% -76.58% -257.71% -12.40% -195.43%
Current Ratio 0.23× 0.15× 0.20× 0.36× 0.12×
Debt-to-Equity 0.00× -1.04× -4.66× -1.47×
Cash Conversion Ratio -1.63× 1.15× 1.15× -2.44× -1.15×
Accruals Ratio -0.96× 0.12× 0.38× -0.43× -4.21×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2022
Revenues 325.00K 104.45K 27.17K 1.76K
Cost of Revenue 149.90K 0
Gross Profit 175.10K 104.45K
Research and Development Expense 0 26.64K
Operating Expenses 242.29K 395.60K 325.22K 57.05K 21.26K
Operating Income (Loss) -67.19K -291.15K -298.05K
Income Tax Expense (Benefit) 0 0 0
Net Income (Loss) Attributable to Parent -67.15K -136.85K -279.16K -55.29K -21.26K
Earnings Per Share, Basic $-0.01 $-0.03 $-0.06 $-0.01 $-0.01
Weighted Average Number of Shares Outstanding, Basic 4.56M 4.56M 4.33M 4.09M 3.25M
Earnings Per Share, Diluted $-0.03 $-0.06
Weighted Average Number of Shares Outstanding, Diluted 4.56M 4.56M 4.33M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2022
Cash and Cash Equivalents, at Carrying Value 286 2.28K 877
Assets, Current 131.71K 74.19K 86.17K 176.83K 4.14K
Assets 183.55K 178.71K 108.32K 446.03K 10.88K
Liabilities, Current 574.81K 502.82K 433.63K 492.18K 34.07K
Liabilities 574.81K 502.82K 433.63K 492.18K 34.07K
Stockholders' Equity Attributable to Parent -391.26K -324.11K -325.30K -46.15K -23.20K
Common Stock, Shares, Outstanding 4.56M 4.56M 4.56M 4.33M 3.25M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2022
Net Cash Provided by (Used in) Operating Activities 109.45K -157.54K -320.39K 134.88K 24.52K
Net Cash Provided by (Used in) Investing Activities 0 0 241.39K 77.00K -6.74K
Net Cash Provided by (Used in) Financing Activities 22.21K 157.31K 77.01K 213.28K 31.95K

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (ANKM CIK 0001781629), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

MNOV

MEDICINOVA, INC.

UGP

ULTRAPAR HOLDINGS INC.

CYCU

Cycurion, Inc.